Charles River Laboratories International (CRL) Total Liabilities (2009 - 2026)

Charles River Laboratories International has reported Total Liabilities for 18 years, with the latest figure at $4.6 billion in Q2 2026.

• On a quarterly basis, Total Liabilities rose 11.6% year-over-year to $4.6 billion in Q2 2026; TTM through Jun 2026 was $4.6 billion, a 11.6% increase from a year earlier, with the FY2025 full-year figure at $3.9 billion, down 2.39% from the prior year.
• Total Liabilities was $4.6 billion for Q2 2026 at Charles River Laboratories International, down from $4.7 billion in the prior quarter.
• The five-year high for Total Liabilities was $4.8 billion in Q2 2022, with the low at $3.9 billion in Q4 2025.
• Average Total Liabilities over 5 years is $4.4 billion, with a median of $4.4 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities rose 22.59% in 2022, then slipped 11.37% in 2024.
• Over 5 years, Total Liabilities stood at $4.6 billion in 2022, then retreated by 0.94% to $4.5 billion in 2023, then decreased by 11.37% to $4.0 billion in 2024, then declined by 2.39% to $3.9 billion in 2025, then grew by 18.33% to $4.6 billion in 2026.
• The last three Total Liabilities figures came in at $4.6 billion (Q2 2026), $4.7 billion (Q1 2026), and $3.9 billion (Q4 2025), per Business Quant data.